http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2015, Vol. 24 ›› Issue (7): 475-481.DOI: 10.5246/jcps.2015.07.061

• Short communications • Previous Articles     Next Articles

Simultaneous determination of ginsenosides Rg1, Re and Rb1 in rat plasma by HPLC and its application to pharmacokinetic study of SHENMAI injection

Qingdan Xue1, Peng Wang1, Yuhong Kang2, Qiuhong Li1*   

  1. 1. Department of Clinical Pharmacy, College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China 
    2. Teaching and Experiment Center, Heilongjiang University of Chinese Medicine, Harbin 150040, China
  • Received:2015-03-31 Revised:2015-04-28 Online:2015-07-28 Published:2015-05-15
  • Contact: Tel.: 86-0451-87266902
  • Supported by:
    Science and Technology Research project of Heilongjiang Province Department of Education (Grant No. 12541740).

Abstract:

In the present study, we developed a sensitive and efficient high performance liquid chromatography (HPLC) method for the simultaneous determination of three ginsenosides (Rg1, Re, Rb1) in rat plasma. Chromatographic separation was performed on a C18 (150 mm×4.6 mm) column utilizing gradient elution profile and a mobile phase consisting of (A) water and (B) acetonitrile. The calibration curve, with a great correlation coefficient greater than 0.998, was linear over the range of 1.0–30.0 μg/mL for ginsenoside Rg1, 0.5–15.0 μg/mL for ginsenoside Re, and 0.5–200.0 μg/mL for ginsenoside Rb1. The intra- and inter-day precisions for three ginsenosides (Rg1, Re, Rb1) were all less than 6.0%, and average recovery, examined at three concentration levels, ranged from 96.1% to 118.6%. The samples was stable within 24 h at 4 ºC storage, and 30 d at –20 ºC storage with three freeze-thaw-assay cycles. The low limits of quantification (LOQ) were 1.0, 0.5 and 0.5 μg/mL for Rg1,Re and Rb1, respectively. Taken together, the newly developed method was successfully applied to study the pharmacokinetics of ginsenoside Rg1, Re and Rb1 in rat plasma after intravenous administration of SHENMAI injection (SMI).

Key words: Ginsenoside Rg1, Re, Rb1, HPLC, SHENMAI injection, Plasma

CLC Number: 

Supporting: